ASN Press Releases: 2026
Latest Release: Advanced Age Does Not Limit the Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Chronic Kidney Disease
Saturday, October 24, 2026
• Real-world data indicate that sodium-glucose cotransporter 2 inhibitors may reduce risks of all-cause mortality and major adverse kidney events in adults aged 80 years or older with chronic kidney disease, although the medications are not without risk. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Subscribe to ASN Press Releases
Stay on top of the latest happenings with the Society and in the nephrology world by subscribing to the ASN Press Release RSS Feed.
More Press Releases
- US–Mexico Border Counties Face High Kidney Disease –Related Mortality and Low Nephrologist Availability
• Counties along the US–Mexico border have limited access to nephrology care, and this limited access is associated with higher chronic kidney disease-related mortality. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Friday, October 23, 2026 - Phase 2 BESTOW Trial Generates Promising Kidney Function and Quality of Life Results for Tegoprubart Versus Tacrolimus Immunosuppression in Kidney Transplant Recipients
• An analysis of BESTOW trial results indicates that kidney transplant recipients treated with tegoprubart not only have better kidney function but also have better health-related quality of life than those taking today's standard of care immunosuppressive drug tacrolimus. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Friday, October 23, 2026 - Standard Kidney Function Tests Underestimate Chronic Kidney Disease in People with Cancer
• Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Friday, October 23, 2026 - Standard Kidney Function Tests Underestimate Chronic Kidney Disease in People with Cancer
• Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Friday, October 23, 2026 - Late Breaking, High-Impact Clinical Trials Featured at Kidney Week 2026 Explore New Frontiers to Improve Kidney Health
The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25. The selected studies explore a wide range of kidney health issues, including transplantation and dialysis treatment, as well as emerging therapies and regimens to treat kidney diseases and co-morbidities.
Friday, October 23, 2026 - Social Determinants of Health Linked with Kidney Failure Risk Among Survivors of Critical Illness and Acute Kidney Injury
• Black race, lack of health insurance, and residence in socioeconomically deprived neighborhoods were associated with higher risks of developing kidney failure among survivors of critical illness and acute kidney injury. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Thursday, October 22, 2026 - Potassium Binder May Ease the Burden of Dietary Potassium Restriction in People on Dialysis
• In a randomized trial of adults on hemodialysis with hyperkalemia, the potassium binder sodium zirconium cyclosilicate improved quality of life related to dietary potassium restriction and lowered serum potassium. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Thursday, October 22, 2026 - Fruits and Vegetables Outperform Medication for Treating Metabolic Acidosis in Chronic Kidney Disease
Addressing metabolic acidosis with fruits and vegetables was associated with more favorable long-term clinical outcomes and health care utilization than standard treatment. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.
Thursday, October 22, 2026 - High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health
The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2026 October 22–25. •
Thursday, October 22, 2026 - AMERICAN SOCIETY OF NEPHROLOGY ISSUES STATEMENT ON U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES KIDNEY CARE NATIONAL PLAN
The American Society of Nephrology (ASN), today issued the following statement regarding the U.S. Department of Health and Human Services (HHS) release of its Kidney Care National Plan: a coordinated department-wide strategy focused on revitalizing American kidney care. According to HHS, the Plan builds upon the progress made under the 2019 Advancing American Kidney Health Executive Order and outlines policy recommendations to reward innovation, give patients meaningful choices, and hold down costs while improving quality.
Tuesday, October 20, 2026 - AMERICAN SOCIETY OF NEPHROLOGY PUBLISHES KIDNEY HEALTH GUIDANCE FOR NEPHROLOGY HEALTH CARE PROFESSIONALS ON THE CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
• The ASN Kidney Health Guidance (KHG) on the Cardiovascular-Kidney-Metabolic Syndrome and accompanying Executive Summary provide practical guidance to nephrology health care professionals for the diagnosis and management of cardiovascular-kidney-metabolic (CKM) syndrome, with special attention directed toward individualizing treatment approaches for patients with kidney diseases. • The new KHG frames essential aspects of care across the CKM syndrome and emphasizes the clinical and biological interconnectedness of metabolic health, kidney diseases, and cardiovascular diseases, including simultaneous cardiovascular and kidney risk assessment. • The ASN KHG complements the recently published 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome by highlighting the common risk factors, overlapping pathophysiology, and evidence-based pharmacological therapies shared between kidney, metabolic, and cardiovascular diseases.
Wednesday, September 2, 2026 - KIDNEYCURE ANNOUNCES 2026 GRANT RECIPIENTS
• KidneyCure, the ASN Foundation for Kidney Research, is the largest private funder of kidney research and is proud to support a cohort of 56 investigators with over $4 million in 2026 funding.
Wednesday, July 1, 2026 - AMERICAN SOCIETY OF NEPHROLOGY PRESIDENT APPLAUDS INTRODUCTION OF IMPROVING HOME DIALYSIS ACT OF 2026 AND LEADERSHIP ON KIDNEY HEALTH POLICY
The American Society of Nephrology (ASN) commends Congressional Kidney Caucus Co-Chair Representative Carol Miller; House Committee on Ways and Means Chairman Smith and Ranking Member Richard Neal; and Health Subcommittee Chairman Vern Buchanan, and Ranking Member Lloyd Doggett for their ongoing leadership on behalf of the 37 million Americans living with kidney diseases.
Wednesday, May 20, 2026 - AMERICAN SOCIETY OF NEPHROLOGY AND THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES LAUNCH $4M KIDNEYX EMPOWER PRIZE CHALLENGE TO BOOST LIVING KIDNEY DONATION
The American Society of Nephrology (ASN) in collaboration with the U.S. Department of Health and Human Services (HHS), is launching the 2026 KidneyX EMPOWER Prize Challenge, a new $4 million national prize competition to accelerate innovation in support of living kidney donors and the people with kidney diseases whose lives depend on them. The competition, slated to open on April 15, invites submissions from a wide range of participants, including patients, living donors, caregivers, health care professionals, researchers, technology and digital health companies, engineers, and entrepreneurs.
Wednesday, April 15, 2026 - AMERICAN SOCIETY OF NEPHROLOGY HEALTH POLICY SCHOLAR PROVIDES TESTIMONY AT HOUSE COMMITTEE HEARING ON IMPROVING KIDNEY HEALTH THROUGH BETTER PREVENTION AND INNOVATIVE TREATMENT
Today, the American Society of Nephrology (ASN) testified before the House Committee on Ways and Means Subcommittee on Health hearing on Improving Kidney Health through Better Prevention and Innovative Treatment.
Wednesday, March 18, 2026 - AMERICAN SOCIETY OF NEPHROLOGY OFFERS NEW KIDNEY HEALTH GUIDANCE ON CONSERVATIVE MANAGEMENT IN PEOPLE WITH KIDNEY FAILURE
The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG): Conservative Management in People with Kidney Failure, in the Journal of the American Society of Nephrology (JASN). The new KHG, and companion Executive Summary, provides evidence-based support for the core components of the conservative management care pathway, including customized CKD care to align with a person's values and goals, symptom management, and navigation of care transitions through the end of life.
Wednesday, March 18, 2026 - AMERICAN SOCIETY OF NEPHROLOGY CALLS ON CONGRESS TO ADVANCE CRITICAL KIDNEY HEALTH RESEARCH AND SUPPORT LIVING DONORS
Today, leaders from the American Society of Nephrology (ASN) are meeting with their congressional delegations to urge bipartisan support for critical kidney health priorities that can accelerate research, transform care, expand access to transplantation, and strengthen support for living donors.
Tuesday, March 10, 2026 - AMERICAN SOCIETY OF NEPHROLOGY CELEBRATES NEW LEGISLATION TO EXPAND SUPPORT FOR LIVING DONORS
The American Society of Nephrology (ASN) celebrates the introduction of the Expanding Support for Living Donors Act of 2026, legislation that would bolster and expand support for living organ donors.
Monday, March 9, 2026 - AMERICAN SOCIETY OF NEPHROLOGY VOICES SUPPORT FOR STATUTE GALVANIZING ADDITIONAL PROTECTIONS FOR LIVING DONORS
The American Society of Nephrology (ASN) applauds the forthcoming markup of the Living Donor Protection Act of 2025 by the Senate Committee on Health, Labor, Education, and Pensions (HELP) on Thursday, February 26, 2026. This legislation aims to eliminate known barriers to living donation—the optimal form of therapy for most people with kidney failure—by galvanizing key protections in statute.
Wednesday, February 25, 2026 - AMERICAN SOCIETY OF NEPHROLOGY COMMENDS KIDNEY HEALTH CHAMPIONS UPON ENACTMENT OF THE HONOR OUR LIVING DONORS (HOLD) ACT
The American Society of Nephrology (ASN) commends Senator John Boozman (R-AR), Representative Suzan DelBene (D-WA), Senator Ben Ray Luján (D-NM), and Representative Jay Obernolte (R-CA) for their leadership enacting the Honor Our Living Donors (HOLD) Act on February 3, 2026—legislation that will improve financial support for living donors.
Wednesday, February 4, 2026 - SAMIR M. PARIKH, MD, FASN, NAMED PRESIDENT OF THE AMERICAN SOCIETY OF NEPHROLOGY
The American Society of Nephrology (ASN) today announced that Samir M. Parikh, MD, FASN has become the society's president on January 1, 2026. Dr. Parikh succeeds Dr. Prabir Roy-Chaudhury who led ASN in 2025
Thursday, January 1, 2026